Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.
 
 
 


Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

71 - 80 von 117
<< < > >>


Artikel 71 Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018
Enthalten in Advances in therapy Bd. 39, 30.8.2022, Nr. 11, date:11.2022: 5300 		Online Ressource
Artikel 72 Correction to: The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
Enthalten in Advances in therapy Bd. 38, 19.7.2021, Nr. 8, date:8.2021: 4602 		Online Ressource
Artikel 73 Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis
Enthalten in Advances in therapy Bd. 36, 30.5.2019, Nr. 8, date:8.2019: 2086-2095 		Online Ressource
Artikel 74 Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis
Enthalten in BioDrugs Bd. 35, 11.5.2021, Nr. 4, date:7.2021: 469-471 		Online Ressource
Artikel 75 Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018
Enthalten in Advances in therapy Bd. 39, 23.6.2022, Nr. 8, date:8.2022: 3711-3734 		Online Ressource
Artikel 76 Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety
Enthalten in Drugs - real world outcomes Bd. 7, 22.4.2020, Nr. 2, date:6.2020: 131-139 		Online Ressource
Artikel 77 Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis
Enthalten in Arthritis Research & Therapy Bd. 27, 17.7.2025, Nr. 1, date:12.2025: 1-7 		Online Ressource
Artikel 78 Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review
Enthalten in Advances in therapy Bd. 36, 5.6.2019, Nr. 8, date:8.2019: 1851-1877 		Online Ressource
Artikel 79 Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study
Enthalten in Drug safety Bd. 42, 21.6.2019, Nr. 12, date:12.2019: 1437-1447 		Online Ressource
Artikel 80 Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)
Enthalten in BioDrugs Bd. 35, 15.7.2021, Nr. 4, date:7.2021: 417-428 		Online Ressource


71 - 80 von 117
<< < > >>




Materialarten

Alle Materialarten > Artikel (117)

Standorte

Alle Standorte > Leipzig (117)

Aktionen

Aktionen


E-Mail-IconAdministration